Skip to main content
SpringerLink
Log in

Barriers to Achieving Childhood Cancer Cure

  • Living reference work entry
  • First Online:
Pediatric Surgical Oncology

  • 36 Accesses

Abstract

Children who develop cancer in low- and middle-income countries (LMIC) have a lower chance of long-term event-free survival than their counterparts in high-income countries (HIC). Causes of excess treatment failure in LMIC include lack of diagnosis at the secondary and tertiary care level, misdiagnosis, refusal and abandonment of treatment, toxic death, and excess relapse. Each major cause of treatment failure has contributing subcauses and each of these has identified strategies to address them that have documented benefits in both LMIC and HIC. Pediatric oncology surgeons have a key role to play to improve diagnosis, risk stratification, local control, supportive care, and, ultimately, survival.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. World Health Organization. CureAll framework: WHO global initiative for childhood cancer: increasing access, advancing quality, saving lives [Internet]. Geneva: World Health Organization;2021 [cited 2022 Aug 12]. Available from: https://apps.who.int/iris/handle/10665/347370

  2. Rodriguez-Galindo C, Friedrich P, Alcasabas P, Antillon F, Banavali S, Castillo L, et al. Toward the cure of all children with cancer through collaborative efforts: pediatric oncology as a global challenge. J Clin Oncol. 2015;33(27):3065–73.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Ribeiro RC, Steliarova-Foucher E, Ian M, Lemerle J, Eden T, Forget C, et al. Baseline status of paediatric oncology in ten low-income or mid- income countries receiving My Child Matters support: a descriptive study. Lancet Oncol. 2008;9(8):721–9.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Basbous M, Al-Jadiry M, Belgaumi A, Sultan I, Al-Haddad A, Jeha S, et al. Childhood cancer care in the Middle East, North Africa, and West/Central Asia: a snapshot across five countries from the POEM network. Cancer Epidemiol. 2020;71:101727.

    Article  PubMed  Google Scholar 

  5. Force LM, Abdollahpour I, Advani SM, Agius D, Ahmadian E, Alahdab F, et al. The global burden of childhood and adolescent cancer in 2017: an analysis of the Global Burden of Disease Study 2017. Lancet Oncol. 2019;20(9):1211–25.

    Article  Google Scholar 

  6. Howard SC, Metzger ML, Wilimas JA, Quintana Y, Pui CH, Robison LL, et al. Childhood cancer epidemiology in low-income countries. Cancer. 2008;112(3):461–72.

    Article  PubMed  Google Scholar 

  7. Yadav SP, Rastogi N, Kharya G, Misra R, Ramzan M, Katewa S, et al. Barriers to cure for children with cancer in India and strategies to improve outcomes: a report by the Indian Pediatric Hematology Oncology Group. Pediatr Hematol Oncol. 2014;31(3):217–24.

    Article  PubMed  Google Scholar 

  8. Loh AHP, Aung L, Ha C, Tan AM, Quah TC, Chui CH. Diagnostic delay in pediatric solid tumors: a population based study on determinants and impact on outcomes: diagnostic delay in pediatric solid tumors. Pediatr Blood Cancer. 2012;58(4):561–5.

    Article  PubMed  Google Scholar 

  9. Araz NC, Guler E. Delays in diagnosis of childhood cancer in Southeastern Turkey and the associated factors. Pediatr Hematol Oncol. 2015;32(2):153–63.

    Article  CAS  PubMed  Google Scholar 

  10. Zabih W, Thota AB, Mbah G, Freccero P, Gupta S, Denburg AE. Interventions to improve early detection of childhood cancer in low- and middle-income countries: a systematic review. Pediatr Blood Cancer [Internet]. 2020 Dec [cited 2022 Jul 14];67(12). Available from: https://onlinelibrary.wiley.com/doi/10.1002/pbc.28761

  11. Barr RD. “Delays” in diagnosis: a misleading concept, yet providing opportunities for advancing clinical care. J Pediatr Hematol Oncol. 2014;36:169–72.

    Article  PubMed  Google Scholar 

  12. Geel JA, Stevenson BT, Jennings RB, Krook LE, Winnan SJ, Katz BT, et al. Enough is not enough: medical students’ knowledge of early warning signs of childhood cancer. S Afr Med J. 2017;107(7):585.

    Article  PubMed  Google Scholar 

  13. Asana L, Irabor C, Seppo S, Jean C, Ngoma T, Elzawawy A, et al. Using advanced information and communication technologies to advance oncology education in Africa. ecancer [Internet]. 2021 Mar 23 [cited 2022 Aug 12];15. Available from: https://ecancer.org/en/journal/article/1211-using-advanced-information-and-communication-technologies-to-advance-oncology-education-in-africa

  14. Van Heerden J, Kruger M. Management of neuroblastoma in limited-resource settings. WJCO. 2020;11(8):629–43.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Gelband H, Jha P, Sankaranarayanan R, Horton S. Cancer: disease control priorities, vol. 3. 3rd ed.Washington, DC: The International Bank for Reconstruction and Development/The World Bank; 2015.

    Google Scholar 

  16. Wilson ML, Fleming KA, Kuti MA, Looi LM, Lago N, Ru K. Access to pathology and laboratory medicine services: a crucial gap. Lancet. 2018;391(10133):1927–38.

    Article  PubMed  Google Scholar 

  17. Roa L, Moeller E, Fowler Z, Vaz Ferreira R, Mohar S, Uribe-Leitz T, et al. Assessment of diagnostics capacity in hospitals providing surgical care in two Latin American states. EClinicalMedicine. 2020;29–30:100620.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Pérez-Cuevas R, Doubova SV, Zapata-Tarres M, Flores-Hernández S, Frazier L, Rodríguez-Galindo C, et al. Scaling up cancer care for children without medical insurance in developing countries: the case of Mexico: scaling up cancer care for children in Mexico. Pediatr Blood Cancer. 2013;60(2):196–203.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Mostert S, Arora RS, Arreola M, Bagai P, Friedrich P, Gupta S, et al. Abandonment of treatment for childhood cancer: position statement of a SIOP PODC Working Group. Lancet Oncol. 2011;12(8):719–20.

    Article  PubMed  Google Scholar 

  20. Weaver MS, Howard SC, Lam CG. Defining and distinguishing treatment abandonment in patients with cancer. J Pediatr Hematol Oncol. 2015;37(4):252–6.

    Article  PubMed  Google Scholar 

  21. Friedrich P, Lam CG, Kaur G, Itriago E, Ribeiro RC, Arora RS. Determinants of treatment abandonment in childhood cancer: results from a global survey. van Wouwe J, editor. PLoS One. 2016;11(10):e0163090.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Ngwa W, Addai BW, Adewole I, Ainsworth V, Alaro J, Alatise OI, et al. Cancer in sub-Saharan Africa: a Lancet Oncology Commission. Lancet Oncol. 2022;23(6):e251–312.

    Article  CAS  PubMed  Google Scholar 

  23. Salaverria C, Rossell N, Hernandez A, Fuentes Alabi S, Vasquez R, Bonilla M, et al. Interventions targeting absences increase adherence and reduce abandonment of childhood cancer treatment in El Salvador: improving all treatment adherence in El Salvador. Pediatr Blood Cancer. 2015;62(9):1609–15.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Jatia S, Prasad M, Paradkar A, Bhatia A, Narula G, Chinnaswamy G, et al. Holistic support coupled with prospective tracking reduces abandonment in childhood cancers: a report from India. Pediatr Blood Cancer. 2019;66(6):e27716.

    Article  PubMed  Google Scholar 

  25. Kuerer HM, Eberlein TJ, Pollock RE, Huschka M, Baile WF, Morrow M, et al. Career satisfaction, practice patterns and burnout among surgical oncologists: report on the quality of life of members of the society of surgical oncology. Ann Surg Oncol. 2007;14(11):3043–53.

    Article  PubMed  Google Scholar 

  26. Alvarez E, Seppa M, Rivas S, Fuentes L, Valverde P, Antillón-Klussmann F, et al. Improvement in treatment abandonment in pediatric patients with cancer in Guatemala. Pediatr Blood Cancer. 2017;64(10):e26560.

    Article  Google Scholar 

  27. Ospina-Romero M, Portilla CA, Bravo LE, Ramirez O, On behalf of VIGICANCER working group. Caregivers’ self-reported absence of social support networks is related to treatment abandonment in children with cancer: social support and cancer treatment abandonment. Pediatr Blood Cancer. 2016;63(5):825–31.

    Article  PubMed  Google Scholar 

  28. Howard SC, Davidson A, Luna-Fineman S, Israels T, Chantada G, Lam CG, et al. A framework to develop adapted treatment regimens to manage pediatric cancer in low- and middle-income countries: the Pediatric Oncology in Developing Countries (PODC) Committee of the International Pediatric Oncology Society (SIOP). Pediatr Blood Cancer. 2017;64(November):1–18.

    Google Scholar 

  29. Kemp G, Hallbourg M, Altounji D, Secola R. Back to basics: CLABSI reduction through implementation of an oral care and hygiene bundle. J Pediatr Oncol Nurs. 2019;36(5):321–6.

    Article  PubMed  Google Scholar 

  30. Triarico S, Rinninella E, Cintoni M, Capozza MA, Mastrangelo S, Mele MC, Ruggiero A. Impact of malnutrition on survival and infections among pediatric patients with cancer: a retrospective study. Eur Rev Med Pharmacol Sci. 2019;23(3):1165–1175. https://doi.org/10.26355/eurrev_201901_17009. PMID: 30779086.

  31. Sala A, Rossi E, Antillon F, Molina AL, de Maselli T, Bonilla M, et al. Nutritional status at diagnosis is related to clinical outcomes in children and adolescents with cancer: a perspective from Central America. Eur J Cancer. 2012;48(2):243–52.

    Article  PubMed  Google Scholar 

  32. Israëls T, Borgstein E, Jamali M, de Kraker J, Caron HN, Molyneux EM. Acute malnutrition is common in Malawian patients with a Wilms tumour: a role for peanut butter: nutritional status and Wilms tumour. Pediatr Blood Cancer. 2009;53(7):1221–6.

    Article  PubMed  Google Scholar 

  33. Ladas EJ, Arora B, Howard SC, Rogers PC, Mosby TT, Barr RD. A framework for adapted nutritional therapy for children with cancer in low- and middle-income countries: a report from the SIOP PODC Nutrition Working Group: a framework for nutritional care in LMIC. Pediatr Blood Cancer. 2016;63(8):1339–48.

    Article  PubMed  Google Scholar 

  34. Chakaya J, Khan M, Ntoumi F, Aklillu E, Fatima R, Mwaba P, et al. Global tuberculosis report 2020 – reflections on the global TB burden, treatment and prevention efforts. Int J Infect Dis. 2021;113:S7–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Bediako Y, Adams R, Reid AJ, Valletta JJ, Ndungu FM, Sodenkamp J, et al. Repeated clinical malaria episodes are associated with modification of the immune system in children. BMC Med. 2019;17(1):60.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Davidson A, Wainwright RD, Stones DK, Kruger M, Hendricks M, Geel J, et al. Malignancies in South African children with HIV. J Pediatr Hematol Oncol. 2014;36(2):111–7.

    Article  PubMed  Google Scholar 

  37. Chabay PA, Preciado MV. EBV primary infection in childhood and its relation to B-cell lymphoma development: a mini-review from a developing region: EBV primary infection in childhood. Int J Cancer. 2013;133(6):1286–92.

    Article  CAS  PubMed  Google Scholar 

  38. Janssens KP, Valete COS, da Silva ARA, Ferman SE. Evaluation of risk stratification strategies in pediatric patients with febrile neutropenia. J Pediatr. 2021;97(3):302–8.

    Article  Google Scholar 

  39. Ruggiero A, Ferrara P, Attinà G, Rizzo D, Riccardi R. Renal toxicity and chemotherapy in children with cancer. Br J Clin Pharmacol. 2017;83(12):2605–14.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Mudi A, Levy CS, Geel JA, Poole JE. Paediatric cancer survivors demonstrate a high rate of subclinical renal dysfunction. Pediatr Blood Cancer. 2016;63(11):2026.

    Article  CAS  PubMed  Google Scholar 

  41. Wu NL, Hingorani S. Outcomes of kidney injury including dialysis and kidney transplantation in pediatric oncology and hematopoietic cell transplant patients. Pediatr Nephrol. 2021;36(9):2675–86.

    Article  PubMed  Google Scholar 

  42. Raja RA, Schmiegelow K, Frandsen TL. Asparaginase-associated pancreatitis in children. Br J Haematol. 2012;159(1):18–27.

    Article  CAS  PubMed  Google Scholar 

  43. Elitek (rasburicase) package insert for prescribers. https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/103946s5083lbl.pdf

  44. Gopakumar KG, Thankamony P, Seetharam S, P K. Treatment of tumor lysis syndrome in children with leukemia/lymphoma in resource-limited settings-Efficacy of a fixed low-dose rasburicase. Pediatr Hematol Oncol. 2017;34(4):206–211. https://doi.org/10.1080/08880018.2017.1348415. Epub 2017 Sep 5. PMID: 28872997.

  45. Navarrete M, Rossi E, Brivio E, Carrillo JM, Bonilla M, Vasquez R, et al. Treatment of childhood acute lymphoblastic leukemia in Central America: a lower-middle income countries experience: treatment of childhood ALL in Central America. Pediatr Blood Cancer. 2014;61(5):803–9.

    Article  CAS  PubMed  Google Scholar 

  46. Howard SC, Ortiz R, Baez LF, Cabanas R, Fu L, Pen A. Protocol-based treatment for children with cancer in low income countries in Latin America a report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO)—PART II. Pediatr Blood Cancer. 2007;48:486–90.

    Article  PubMed  Google Scholar 

  47. Zubizarreta EH, Fidarova E, Healy B, Rosenblatt E. Need for radiotherapy in low and middle income countries – the silent crisis continues. Clin Oncol. 2015;27(2):107–14.

    Article  CAS  Google Scholar 

  48. Lai J, Widmar NO. Revisiting the digital divide in the COVID -19 era. Appl Econ Perspect Policy. 2021;43(1):458–64.

    Article  PubMed  Google Scholar 

  49. Howard SC, Zaidi A, Cao X, Weil O, Bey P, Patte C, et al. The my child matters programme: effect of public–private partnerships on paediatric cancer care in low-income and middle-income countries. Lancet Oncol. 2018;19(5):e252–66.

    Article  PubMed  Google Scholar 

  50. There are not enough scientists in Africa. How can we turn this around? [Internet]. World Economic Forum [cited 2022 Aug 15]. Available from: https://www.weforum.org/agenda/2017/05/scientists-are-the-key-to-africas-future/

Download references

Author information

Authors and Affiliations

  1. Division of Paediatric Haematology Oncology, Faculty of Health Sciences, University of the Witwatersrand, Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa

    Jennifer Geel

  2. University of Tennessee Health Science Center, Memphis, TN, USA

    Scott Howard

Authors
  1. Jennifer Geel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Scott Howard
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jennifer Geel .

Editor information

Editors and Affiliations

  1. University of Oxford, Oxford, UK

    Kokila Lakhoo

  2. St. Jude Children's Research Hospital, Memphis, TN, USA

    Abdelhafeez H. Abdelhafeez

  3. Federal University of Sao Paulo, Sao Paulo, Brazil

    Simone Abib

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Geel, J., Howard, S. (2023). Barriers to Achieving Childhood Cancer Cure. In: Lakhoo, K., Abdelhafeez, A.H., Abib, S. (eds) Pediatric Surgical Oncology. Springer, Cham. https://doi.org/10.1007/978-3-030-71113-9_6-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-71113-9_6-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-71113-9

  • Online ISBN: 978-3-030-71113-9

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation